Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

Part of paid clinical trials in Fairhope, Alabama.

Sponsor
American Heart Association
Study ID
NCT06461468
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

HCM FLIP study is a two-phase protocol focusing on the detection of Hypertrophic Cardiomyopathy using Electrocardiograms and Echocardiograms through Federated Learning.

Key Dates

Start date
Jun 5, 2024
Status verified
Aug 2024
Primary completion
Jan 31, 2026
Completion
Jan 31, 2026

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: HCM-Labeled Cases
    Cases with maximum left ventricular wall thickness exceeding 15 mm (including the right ventricular component of the septum) without any other explanation for ventricular hypertrophy (e.g., severe hypertension, cardiac amyloidosis, severe aortic stenosis (AS)). The measurement could be made in an echocardiogram or on magnetic resonance imaging (MRI).
  • Arm: Control Cases (Non-HCM)
    No diagnosis of HCM.

Primary Outcome Measure

Diagnosis of HCM [ Time Frame: Through study completion, an average of 2 years ]

Locations (6)

FacilityCityStateZIPSite coordinators
Thomas HospitalFairhopeAlabama36532-
Riverside Medical CenterKankakeeIllinois60901-
Johns Hopkins University School of MedicineBaltimoreMaryland21287-
University of Michigan Medical CenterAnn ArborMichigan48109-
Wooster Community HospitalWoosterOhio44691-
The University of Texas Southwestern Medical CenterDallasTexas75390-

Find similar trials in Fairhope, AL

By research site
Thomas Hospital· Fairhope, ALRiverside Medical Center· Kankakee, ILJohns Hopkins University School of Medicine· Baltimore, MDUniversity of Michigan Medical Center· Ann Arbor, MIWooster Community Hospital· Wooster, OHThe University of Texas Southwestern Medical Center· Dallas, TX

Related Studies